|
|
 |
|
Viewing report
|
|
|
|
Baylor Research Institute - Developmental Therapeutics Review - Q4 2010
Global Markets Direct, Dec 2010, Pages: 32
Baylor Research Institute – Developmental Therapeutics Review – Q4 2010
Summary
Global Market Direct’s pharmaceuticals report, “Baylor Research Institute – Developmental Therapeutics Review – Q4 2010” provides data on the institute’s research and development focus. The report includes information on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable).
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, institute’s website, and featured press releases, both from institute and industry-specific third party sources, put together by Global Markets Direct’s team of industry experts.
Scope
- Review of therapeutics under development by Baylor Research Institute.
- Overview of products under development across various therapy areas.
- Coverage of therapeutic molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Baylor Research Institute with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of Baylor Research Institute’s therapeutic products in the last quarter.
- Latest news and deals relating to the products.
Reasons to buy
- Review of therapeutics under development by Baylor Research Institute.
- Overview of products under development across various therapy areas.
- Coverage of therapeutic molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Baylor Research Institute with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of Baylor Research Institute’s therapeutic products in the last quarter.
- Latest news and deals relating to the products.
|
|
|
|
